CNCE - Concert Pharmaceuticals Stock Trading

Concert Pharmaceuticals Inc.(NASDAQ: CNCE) stock trading, description, contact, officers and directors.

About Concert Pharmaceuticals Inc.

Not available

Stock Information

Concert Pharmaceuticals Inc. Company Name:

CNCE Stock Symbol:

NASDAQ Market:

Get CNCE Alerts

News, Short Squeeze, Breakout and More Instantly...

CNCE - Concert Pharmaceuticals, Inc. (CNCE) Q3 2020 Earnings Call Transcript

Image source: The Motley Fool. Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) Q3 2020 Earnings Call Nov 6, 2020 , 8:30 p.m. ET Operator Continue reading For further details see: Concert Pharmaceuticals, Inc. (CNCE) Q3 2020 Earnings Call Tra...
CNCE - Concert Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Company Update

CTP-543 THRIVE-AA1 Phase 3 Trial Initiated in Patients with Moderate to Severe Alopecia Areata CTP-543 Treatment Shows Maintenance of Hair Regrowth in Open Label Extension Trial; Data Presented at EADV Virtual Meeting CTP-692 Phase 2 Trial Fully Enrolled; Top...
CNCE - Concert Pharmaceuticals Initiates THRIVE-AA1 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced it has initiated THRIVE-AA1, the first Phase 3 clinical trial to evaluate the efficacy and safety of CTP-543, an oral Janus kinase inhibitor, in adult patients with moderate to severe alopecia areata. The Company expects t...